

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.50404007 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.35105729 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.96133360 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.96133360 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.85729944 |
| 6 | electron transport chain (GO:0022900) | 5.71885974 |
| 7 | glycosphingolipid catabolic process (GO:0046479) | 4.16853530 |
| 8 | protein complex biogenesis (GO:0070271) | 3.87562001 |
| 9 | complement activation, alternative pathway (GO:0006957) | 3.85472689 |
| 10 | phospholipid efflux (GO:0033700) | 3.82525921 |
| 11 | glycolipid catabolic process (GO:0019377) | 3.77868557 |
| 12 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74359134 |
| 13 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74359134 |
| 14 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.67147188 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.66799805 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.66799805 |
| 17 | hydrogen ion transmembrane transport (GO:1902600) | 3.60938357 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60852816 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 3.60852816 |
| 20 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.59607998 |
| 21 | NADH dehydrogenase complex assembly (GO:0010257) | 3.59607998 |
| 22 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.59607998 |
| 23 | ATP biosynthetic process (GO:0006754) | 3.55734572 |
| 24 | oligosaccharide catabolic process (GO:0009313) | 3.50412945 |
| 25 | NADH metabolic process (GO:0006734) | 3.50209148 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.49471197 |
| 27 | negative regulation of sterol transport (GO:0032372) | 3.47349925 |
| 28 | negative regulation of cholesterol transport (GO:0032375) | 3.47349925 |
| 29 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.43800183 |
| 30 | urea metabolic process (GO:0019627) | 3.43574232 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 3.41734699 |
| 32 | inner mitochondrial membrane organization (GO:0007007) | 3.35158854 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 3.33142322 |
| 34 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.32510761 |
| 35 | succinate metabolic process (GO:0006105) | 3.32226469 |
| 36 | regulation of mononuclear cell migration (GO:0071675) | 3.31132672 |
| 37 | regulation of oxidative phosphorylation (GO:0002082) | 3.31094658 |
| 38 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.30924253 |
| 39 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.29206293 |
| 40 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.29206293 |
| 41 | urea cycle (GO:0000050) | 3.27368686 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 3.27248224 |
| 43 | ceramide catabolic process (GO:0046514) | 3.27073262 |
| 44 | proton transport (GO:0015992) | 3.24481006 |
| 45 | hydrogen transport (GO:0006818) | 3.22623392 |
| 46 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17582063 |
| 47 | tricarboxylic acid cycle (GO:0006099) | 3.15895781 |
| 48 | chaperone-mediated protein transport (GO:0072321) | 3.13794400 |
| 49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11482827 |
| 50 | cholesterol efflux (GO:0033344) | 3.08447492 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.05568657 |
| 52 | fibrinolysis (GO:0042730) | 3.05225769 |
| 53 | plasma lipoprotein particle assembly (GO:0034377) | 3.04558600 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 3.04497822 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.02564670 |
| 56 | omega-hydroxylase P450 pathway (GO:0097267) | 3.01317669 |
| 57 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.99991862 |
| 58 | oxidative phosphorylation (GO:0006119) | 2.97539204 |
| 59 | protein-lipid complex assembly (GO:0065005) | 2.95548899 |
| 60 | plasma lipoprotein particle remodeling (GO:0034369) | 2.95100483 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 2.95100483 |
| 62 | macromolecular complex remodeling (GO:0034367) | 2.95100483 |
| 63 | detection of calcium ion (GO:0005513) | 2.93664697 |
| 64 | ketone body metabolic process (GO:1902224) | 2.93316258 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 2.92480090 |
| 66 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91792821 |
| 67 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.91656631 |
| 68 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.90540731 |
| 69 | pinocytosis (GO:0006907) | 2.90311077 |
| 70 | sphingolipid catabolic process (GO:0030149) | 2.88751547 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 2.87321858 |
| 72 | presynaptic membrane assembly (GO:0097105) | 2.86353530 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 2.85607948 |
| 74 | short-chain fatty acid metabolic process (GO:0046459) | 2.85084269 |
| 75 | membrane lipid catabolic process (GO:0046466) | 2.81881863 |
| 76 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81593965 |
| 77 | B cell mediated immunity (GO:0019724) | 2.79933979 |
| 78 | amino sugar catabolic process (GO:0046348) | 2.79361007 |
| 79 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.78378397 |
| 80 | aldehyde catabolic process (GO:0046185) | 2.75683614 |
| 81 | aromatic amino acid family catabolic process (GO:0009074) | 2.75561610 |
| 82 | regulation of superoxide anion generation (GO:0032928) | 2.75122317 |
| 83 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.74304886 |
| 84 | coenzyme catabolic process (GO:0009109) | 2.73949689 |
| 85 | regulation of macrophage chemotaxis (GO:0010758) | 2.73398177 |
| 86 | angiotensin maturation (GO:0002003) | 2.73145367 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.72397197 |
| 88 | GDP-mannose metabolic process (GO:0019673) | 2.70421154 |
| 89 | oxaloacetate metabolic process (GO:0006107) | 2.67749880 |
| 90 | response to thyroid hormone (GO:0097066) | 2.65315446 |
| 91 | response to peptidoglycan (GO:0032494) | 2.65268523 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 2.64902641 |
| 93 | drug catabolic process (GO:0042737) | 2.64421056 |
| 94 | exogenous drug catabolic process (GO:0042738) | 2.61945035 |
| 95 | presynaptic membrane organization (GO:0097090) | 2.60957458 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 2.59625847 |
| 97 | acute-phase response (GO:0006953) | 2.59616633 |
| 98 | positive regulation of antigen processing and presentation (GO:0002579) | 2.57596094 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 2.57325594 |
| 100 | generation of precursor metabolites and energy (GO:0006091) | 2.56845466 |
| 101 | respiratory chain complex IV assembly (GO:0008535) | 2.56070907 |
| 102 | response to interferon-beta (GO:0035456) | 2.55585262 |
| 103 | myeloid dendritic cell activation (GO:0001773) | 2.55487517 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 2.55013272 |
| 105 | protein carboxylation (GO:0018214) | 2.53773167 |
| 106 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.53773167 |
| 107 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.53061247 |
| 108 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.52804496 |
| 109 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.52221106 |
| 110 | cyclooxygenase pathway (GO:0019371) | 2.51895547 |
| 111 | eosinophil chemotaxis (GO:0048245) | 2.51352883 |
| 112 | bile acid biosynthetic process (GO:0006699) | 2.51210984 |
| 113 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51207458 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 2.50394494 |
| 115 | dicarboxylic acid catabolic process (GO:0043649) | 2.50008104 |
| 116 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.49907312 |
| 117 | aerobic respiration (GO:0009060) | 2.49335308 |
| 118 | protein-lipid complex subunit organization (GO:0071825) | 2.48762785 |
| 119 | ubiquinone biosynthetic process (GO:0006744) | 2.47306617 |
| 120 | quinone biosynthetic process (GO:1901663) | 2.47306617 |
| 121 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46361339 |
| 122 | regulation of protein activation cascade (GO:2000257) | 2.45836030 |
| 123 | aspartate family amino acid catabolic process (GO:0009068) | 2.45008798 |
| 124 | dopamine transport (GO:0015872) | 2.44209496 |
| 125 | glyoxylate metabolic process (GO:0046487) | 2.44183532 |
| 126 | regulation of triglyceride catabolic process (GO:0010896) | 2.44142175 |
| 127 | GTP biosynthetic process (GO:0006183) | 2.44088135 |
| 128 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.44025860 |
| 129 | cytochrome complex assembly (GO:0017004) | 2.43721125 |
| 130 | synaptic vesicle exocytosis (GO:0016079) | 2.43512516 |
| 131 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42974790 |
| 132 | reactive oxygen species biosynthetic process (GO:1903409) | 2.42379517 |
| 133 | regulation of chemokine biosynthetic process (GO:0045073) | 2.40649962 |
| 134 | proteasome assembly (GO:0043248) | 2.40551481 |
| 135 | negative regulation of blood coagulation (GO:0030195) | 2.40391390 |
| 136 | negative regulation of hemostasis (GO:1900047) | 2.40391390 |
| 137 | branched-chain amino acid catabolic process (GO:0009083) | 2.40358464 |
| 138 | complement activation (GO:0006956) | 2.40329382 |
| 139 | transferrin transport (GO:0033572) | 2.39521630 |
| 140 | neuron cell-cell adhesion (GO:0007158) | 2.39324410 |
| 141 | proline metabolic process (GO:0006560) | 2.38703331 |
| 142 | regulation of antigen processing and presentation (GO:0002577) | 2.38498222 |
| 143 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.36236410 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.35589433 |
| 145 | flavonoid metabolic process (GO:0009812) | 2.34867579 |
| 146 | vitamin biosynthetic process (GO:0009110) | 2.33929860 |
| 147 | T-helper 1 type immune response (GO:0042088) | 2.33064646 |
| 148 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.32609808 |
| 149 | negative regulation of coagulation (GO:0050819) | 2.32608699 |
| 150 | N-acetylneuraminate metabolic process (GO:0006054) | 2.32168063 |
| 151 | trivalent inorganic cation transport (GO:0072512) | 2.31989019 |
| 152 | ferric iron transport (GO:0015682) | 2.31989019 |
| 153 | protein localization to cilium (GO:0061512) | 2.31933303 |
| 154 | vocalization behavior (GO:0071625) | 2.31571929 |
| 155 | lipoprotein metabolic process (GO:0042157) | 2.31358745 |
| 156 | regulation of complement activation (GO:0030449) | 2.31150647 |
| 157 | aromatic amino acid family metabolic process (GO:0009072) | 2.30623212 |
| 158 | glycoside metabolic process (GO:0016137) | 2.30451700 |
| 159 | behavioral response to cocaine (GO:0048148) | 2.30269028 |
| 160 | fatty acid catabolic process (GO:0009062) | 2.30009346 |
| 161 | ubiquinone metabolic process (GO:0006743) | 2.25644231 |
| 162 | axoneme assembly (GO:0035082) | 2.24155396 |
| 163 | fatty acid beta-oxidation (GO:0006635) | 2.23867764 |
| 164 | neuronal action potential propagation (GO:0019227) | 2.23799862 |
| 165 | regulation of catecholamine metabolic process (GO:0042069) | 2.22939592 |
| 166 | regulation of dopamine metabolic process (GO:0042053) | 2.22939592 |
| 167 | regulation of cholesterol esterification (GO:0010872) | 2.22009972 |
| 168 | tyrosine metabolic process (GO:0006570) | 2.21761418 |
| 169 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.20961619 |
| 170 | cofactor catabolic process (GO:0051187) | 2.20940560 |
| 171 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.20791342 |
| 172 | regulation of cellular respiration (GO:0043457) | 2.19710909 |
| 173 | monocarboxylic acid catabolic process (GO:0072329) | 2.18834580 |
| 174 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.18829614 |
| 175 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.17283362 |
| 176 | lysine catabolic process (GO:0006554) | 2.14750888 |
| 177 | lysine metabolic process (GO:0006553) | 2.14750888 |
| 178 | lipid oxidation (GO:0034440) | 2.14187285 |
| 179 | glutamate metabolic process (GO:0006536) | 2.13386093 |
| 180 | gluconeogenesis (GO:0006094) | 2.12940831 |
| 181 | fatty acid oxidation (GO:0019395) | 2.12647754 |
| 182 | postsynaptic membrane organization (GO:0001941) | 2.12597944 |
| 183 | quinone metabolic process (GO:1901661) | 2.11148299 |
| 184 | cysteine metabolic process (GO:0006534) | 2.10755037 |
| 185 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.10273419 |
| 186 | cellular respiration (GO:0045333) | 2.09824580 |
| 187 | positive regulation of amino acid transport (GO:0051957) | 2.09536334 |
| 188 | regulation of glutamate secretion (GO:0014048) | 2.09450467 |
| 189 | striatum development (GO:0021756) | 2.08458652 |
| 190 | tryptophan catabolic process (GO:0006569) | 2.08031537 |
| 191 | indolalkylamine catabolic process (GO:0046218) | 2.08031537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.64377382 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.81753513 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.47496977 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45552049 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.02761133 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.89814894 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.79391662 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.75646702 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.43208465 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.28813823 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27066536 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.26874780 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.26138254 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20739039 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19839027 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04266011 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90378046 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89858715 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88799096 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.88145182 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.87872109 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87280602 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87221362 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86795987 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.86726932 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86241823 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.86137277 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85838103 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83274059 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82131284 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.81847312 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.81570921 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80624867 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80107132 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80026757 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76923386 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75906197 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74436438 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73358116 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72109746 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71849341 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.70680015 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70652796 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68741992 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68177354 |
| 46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.66468070 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66126122 |
| 48 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66065255 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65170060 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65170060 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62996406 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61592926 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60229193 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60138374 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60059607 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59894692 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59095164 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55408014 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52590120 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51668799 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.51290789 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50175215 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47303541 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47263877 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47224889 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46450083 |
| 67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46330069 |
| 68 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45764232 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43688295 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43170586 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43144981 |
| 72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.42788648 |
| 73 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.42200155 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42054515 |
| 75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40870810 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40002589 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39465290 |
| 78 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38679242 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37664601 |
| 80 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.37494450 |
| 81 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.37476580 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35681452 |
| 83 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34935381 |
| 84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34810029 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33758182 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33754491 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31816439 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31218064 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31013468 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26951346 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26698899 |
| 92 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.25591457 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24992811 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23592090 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23230615 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23097940 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22349218 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22276819 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21918339 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21677109 |
| 101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20942405 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20037801 |
| 103 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19464366 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18052527 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17456168 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17145667 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 1.15987382 |
| 108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14892865 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14259126 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13651271 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13383385 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13201219 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13087622 |
| 114 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12698220 |
| 115 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.12444002 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12408281 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12032915 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11628143 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11597891 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11450118 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11050658 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10882282 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10635785 |
| 124 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10387710 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09151874 |
| 126 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.08551245 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08123576 |
| 128 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08040171 |
| 129 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07639360 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06215480 |
| 131 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05821555 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05608540 |
| 133 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05271148 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04763472 |
| 135 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04725669 |
| 136 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04493938 |
| 137 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04101250 |
| 138 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03549914 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03260277 |
| 140 | MAF_26560356_Chip-Seq_TH1_Human | 1.03247582 |
| 141 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02714107 |
| 142 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02703179 |
| 143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02698100 |
| 144 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02625673 |
| 145 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02120100 |
| 146 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00901527 |
| 147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00479470 |
| 148 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00361034 |
| 149 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99881848 |
| 150 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99849349 |
| 151 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99527519 |
| 152 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97781957 |
| 153 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97536646 |
| 154 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97310304 |
| 155 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96952021 |
| 156 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96777294 |
| 157 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96412598 |
| 158 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96340001 |
| 159 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95736254 |
| 160 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95677649 |
| 161 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94452400 |
| 162 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93555430 |
| 163 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92675368 |
| 164 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92076122 |
| 165 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91404973 |
| 166 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91335518 |
| 167 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90525888 |
| 168 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89264276 |
| 169 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.88983387 |
| 170 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88056132 |
| 171 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87744450 |
| 172 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87589974 |
| 173 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87244925 |
| 174 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87118123 |
| 175 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86819033 |
| 176 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86381407 |
| 177 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85675643 |
| 178 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85359610 |
| 179 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.85164235 |
| 180 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84748724 |
| 181 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84654454 |
| 182 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83460206 |
| 183 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.83447527 |
| 184 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83133717 |
| 185 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82958539 |
| 186 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82891452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 4.13039507 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.99893546 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.25526605 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.05339249 |
| 5 | MP0005360_urolithiasis | 2.79160947 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.72181954 |
| 7 | MP0006082_CNS_inflammation | 2.66444192 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.60241233 |
| 9 | MP0003880_abnormal_central_pattern | 2.58545828 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.52351948 |
| 11 | MP0005451_abnormal_body_composition | 2.47327050 |
| 12 | MP0005365_abnormal_bile_salt | 2.44900754 |
| 13 | MP0003303_peritoneal_inflammation | 2.42674280 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.36120309 |
| 15 | MP0002822_catalepsy | 2.32919683 |
| 16 | MP0004043_abnormal_pH_regulation | 2.29113880 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.28813357 |
| 18 | MP0009785_altered_susceptibility_to | 2.28540464 |
| 19 | MP0003195_calcinosis | 2.17530582 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.16104748 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.15266359 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.15242895 |
| 23 | MP0003436_decreased_susceptibility_to | 2.15219857 |
| 24 | MP0002254_reproductive_system_inflammat | 2.11641323 |
| 25 | MP0002876_abnormal_thyroid_physiology | 2.10051800 |
| 26 | MP0005671_abnormal_response_to | 2.08279355 |
| 27 | MP0002638_abnormal_pupillary_reflex | 2.06679691 |
| 28 | MP0001529_abnormal_vocalization | 2.01223217 |
| 29 | MP0002419_abnormal_innate_immunity | 2.00343957 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.98617714 |
| 31 | MP0005025_abnormal_response_to | 1.96580999 |
| 32 | MP0009745_abnormal_behavioral_response | 1.91132783 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.89072607 |
| 34 | MP0003186_abnormal_redox_activity | 1.85133632 |
| 35 | MP0001853_heart_inflammation | 1.82256125 |
| 36 | MP0009764_decreased_sensitivity_to | 1.82197759 |
| 37 | MP0000604_amyloidosis | 1.82167819 |
| 38 | MP0002064_seizures | 1.79057880 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.78369612 |
| 40 | MP0005332_abnormal_amino_acid | 1.77404272 |
| 41 | MP0001984_abnormal_olfaction | 1.77137493 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.75756997 |
| 43 | MP0002736_abnormal_nociception_after | 1.74434737 |
| 44 | MP0005387_immune_system_phenotype | 1.72251067 |
| 45 | MP0001790_abnormal_immune_system | 1.72251067 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.71538369 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.71331349 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 1.70551258 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.69597734 |
| 50 | MP0008469_abnormal_protein_level | 1.67549970 |
| 51 | MP0003075_altered_response_to | 1.66235753 |
| 52 | MP0000685_abnormal_immune_system | 1.66180451 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.65989034 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.65757783 |
| 55 | MP0000343_altered_response_to | 1.63841417 |
| 56 | MP0009046_muscle_twitch | 1.62294555 |
| 57 | MP0001440_abnormal_grooming_behavior | 1.61652814 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.59751927 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.59458559 |
| 60 | MP0002272_abnormal_nervous_system | 1.58017660 |
| 61 | MP0004142_abnormal_muscle_tone | 1.56425327 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.53171254 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.52864880 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.50658217 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.50145669 |
| 66 | MP0003646_muscle_fatigue | 1.49231126 |
| 67 | MP0002723_abnormal_immune_serum | 1.48460644 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 1.47224730 |
| 69 | MP0002063_abnormal_learning/memory/cond | 1.46995779 |
| 70 | MP0005535_abnormal_body_temperature | 1.46967358 |
| 71 | MP0001905_abnormal_dopamine_level | 1.46055600 |
| 72 | MP0004510_myositis | 1.40623812 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.39952186 |
| 74 | MP0004270_analgesia | 1.39862016 |
| 75 | MP0001486_abnormal_startle_reflex | 1.39755013 |
| 76 | MP0000751_myopathy | 1.39493577 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 1.37572668 |
| 78 | MP0001800_abnormal_humoral_immune | 1.36767656 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.36063584 |
| 80 | MP0003724_increased_susceptibility_to | 1.35796161 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.35368435 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.35368435 |
| 83 | MP0000858_altered_metastatic_potential | 1.35049945 |
| 84 | MP0004859_abnormal_synaptic_plasticity | 1.33836530 |
| 85 | MP0003011_delayed_dark_adaptation | 1.33745028 |
| 86 | MP0001666_abnormal_nutrient_absorption | 1.31261043 |
| 87 | MP0009379_abnormal_foot_pigmentation | 1.29890588 |
| 88 | MP0002067_abnormal_sensory_capabilities | 1.29565645 |
| 89 | MP0002420_abnormal_adaptive_immunity | 1.28406434 |
| 90 | MP0001819_abnormal_immune_cell | 1.28157449 |
| 91 | MP0008004_abnormal_stomach_pH | 1.27050358 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.25767045 |
| 93 | MP0003137_abnormal_impulse_conducting | 1.25625417 |
| 94 | MP0010329_abnormal_lipoprotein_level | 1.24951550 |
| 95 | MP0001502_abnormal_circadian_rhythm | 1.24728902 |
| 96 | MP0002735_abnormal_chemical_nociception | 1.24586400 |
| 97 | MP0002909_abnormal_adrenal_gland | 1.24556877 |
| 98 | MP0005386_behavior/neurological_phenoty | 1.24207673 |
| 99 | MP0004924_abnormal_behavior | 1.24207673 |
| 100 | MP0006054_spinal_hemorrhage | 1.24093450 |
| 101 | MP0005166_decreased_susceptibility_to | 1.20979577 |
| 102 | MP0000609_abnormal_liver_physiology | 1.19566805 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 1.19454665 |
| 104 | MP0000013_abnormal_adipose_tissue | 1.18547119 |
| 105 | MP0001533_abnormal_skeleton_physiology | 1.17880640 |
| 106 | MP0001188_hyperpigmentation | 1.16578701 |
| 107 | MP0003252_abnormal_bile_duct | 1.15792264 |
| 108 | MP0001970_abnormal_pain_threshold | 1.14803042 |
| 109 | MP0003448_altered_tumor_morphology | 1.14307970 |
| 110 | MP0004036_abnormal_muscle_relaxation | 1.13965838 |
| 111 | MP0002557_abnormal_social/conspecific_i | 1.13428321 |
| 112 | MP0005636_abnormal_mineral_homeostasis | 1.13186414 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 1.12715996 |
| 114 | MP0005083_abnormal_biliary_tract | 1.11341183 |
| 115 | MP0009763_increased_sensitivity_to | 1.10964974 |
| 116 | MP0009278_abnormal_bone_marrow | 1.10934336 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 1.10023074 |
| 118 | MP0008260_abnormal_autophagy | 1.08336458 |
| 119 | MP0008872_abnormal_physiological_respon | 1.08110460 |
| 120 | MP0003879_abnormal_hair_cell | 1.07137794 |
| 121 | MP0002163_abnormal_gland_morphology | 1.05626403 |
| 122 | MP0001764_abnormal_homeostasis | 1.04658694 |
| 123 | MP0002733_abnormal_thermal_nociception | 1.04538350 |
| 124 | MP0002405_respiratory_system_inflammati | 1.03608785 |
| 125 | MP0002078_abnormal_glucose_homeostasis | 1.02391908 |
| 126 | MP0004085_abnormal_heartbeat | 1.02362889 |
| 127 | MP0000230_abnormal_systemic_arterial | 1.01566122 |
| 128 | MP0001664_abnormal_digestion | 1.01297597 |
| 129 | MP0002998_abnormal_bone_remodeling | 1.00999940 |
| 130 | MP0000490_abnormal_crypts_of | 1.00760470 |
| 131 | MP0003122_maternal_imprinting | 0.98719936 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.98177133 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.97822231 |
| 134 | MP0002118_abnormal_lipid_homeostasis | 0.97008835 |
| 135 | MP0000716_abnormal_immune_system | 0.96115959 |
| 136 | MP0002132_abnormal_respiratory_system | 0.94643798 |
| 137 | MP0005310_abnormal_salivary_gland | 0.93157248 |
| 138 | MP0009697_abnormal_copulation | 0.92206029 |
| 139 | MP0000749_muscle_degeneration | 0.92085873 |
| 140 | MP0000538_abnormal_urinary_bladder | 0.89420764 |
| 141 | MP0002090_abnormal_vision | 0.88760446 |
| 142 | MP0002229_neurodegeneration | 0.86728809 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.86670237 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.86409534 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.85457622 |
| 146 | MP0002429_abnormal_blood_cell | 0.85380188 |
| 147 | MP0003329_amyloid_beta_deposits | 0.84732771 |
| 148 | MP0009643_abnormal_urine_homeostasis | 0.84669316 |
| 149 | MP0005165_increased_susceptibility_to | 0.84405214 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83963016 |
| 151 | MP0005330_cardiomyopathy | 0.83860353 |
| 152 | MP0005167_abnormal_blood-brain_barrier | 0.82411700 |
| 153 | MP0005253_abnormal_eye_physiology | 0.82165680 |
| 154 | MP0005408_hypopigmentation | 0.81823474 |
| 155 | MP0005620_abnormal_muscle_contractility | 0.81800292 |
| 156 | MP0003300_gastrointestinal_ulcer | 0.81349401 |
| 157 | MP0004947_skin_inflammation | 0.80587449 |
| 158 | MP0004145_abnormal_muscle_electrophysio | 0.80284227 |
| 159 | MP0002398_abnormal_bone_marrow | 0.80248869 |
| 160 | MP0009780_abnormal_chondrocyte_physiolo | 0.79907921 |
| 161 | MP0002972_abnormal_cardiac_muscle | 0.79745004 |
| 162 | MP0003953_abnormal_hormone_level | 0.79212762 |
| 163 | MP0003183_abnormal_peptide_metabolism | 0.78661164 |
| 164 | MP0003868_abnormal_feces_composition | 0.78413831 |
| 165 | MP0009765_abnormal_xenobiotic_induced | 0.78253370 |
| 166 | MP0004883_abnormal_blood_vessel | 0.74914990 |
| 167 | MP0002722_abnormal_immune_system | 0.74643311 |
| 168 | MP0000598_abnormal_liver_morphology | 0.69363061 |
| 169 | MP0001663_abnormal_digestive_system | 0.67441074 |
| 170 | MP0003453_abnormal_keratinocyte_physiol | 0.67178836 |
| 171 | MP0005164_abnormal_response_to | 0.66991785 |
| 172 | MP0010307_abnormal_tumor_latency | 0.65606452 |
| 173 | MP0001873_stomach_inflammation | 0.64999554 |
| 174 | MP0003690_abnormal_glial_cell | 0.63680040 |
| 175 | MP0003656_abnormal_erythrocyte_physiolo | 0.61994279 |
| 176 | MP0005376_homeostasis/metabolism_phenot | 0.60496203 |
| 177 | MP0001727_abnormal_embryo_implantation | 0.59485418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.35716215 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.78531258 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.77445587 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.77445587 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.77445587 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.48786953 |
| 7 | Acute encephalopathy (HP:0006846) | 5.33037162 |
| 8 | Mitochondrial inheritance (HP:0001427) | 5.10773692 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.99301111 |
| 10 | Complement deficiency (HP:0004431) | 4.71509633 |
| 11 | Hepatocellular necrosis (HP:0001404) | 4.46296068 |
| 12 | Hepatic necrosis (HP:0002605) | 4.42539164 |
| 13 | Increased CSF lactate (HP:0002490) | 4.38210137 |
| 14 | Cerebral edema (HP:0002181) | 4.25538483 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.94818083 |
| 16 | Abnormality of complement system (HP:0005339) | 3.91475308 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.85575516 |
| 18 | Glomerulonephritis (HP:0000099) | 3.77396752 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.59363860 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48989253 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.47327356 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46732735 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.45654245 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.40181605 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 3.39415116 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 3.35763031 |
| 27 | Deep venous thrombosis (HP:0002625) | 3.33686067 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.32751711 |
| 29 | Optic disc pallor (HP:0000543) | 3.30972301 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 3.25402430 |
| 31 | Lactic acidosis (HP:0003128) | 3.23999990 |
| 32 | Increased muscle lipid content (HP:0009058) | 3.10796090 |
| 33 | Purpura (HP:0000979) | 3.10565130 |
| 34 | Respiratory failure (HP:0002878) | 3.08630221 |
| 35 | Exercise intolerance (HP:0003546) | 3.06677690 |
| 36 | Upper motor neuron abnormality (HP:0002127) | 3.05953443 |
| 37 | Loss of speech (HP:0002371) | 3.00756393 |
| 38 | Recurrent abscess formation (HP:0002722) | 3.00158586 |
| 39 | Focal motor seizures (HP:0011153) | 2.92560970 |
| 40 | Ketoacidosis (HP:0001993) | 2.91874812 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.88011699 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.86560635 |
| 43 | Axonal loss (HP:0003447) | 2.86396693 |
| 44 | Glycosuria (HP:0003076) | 2.86268917 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 2.86268917 |
| 46 | Pheochromocytoma (HP:0002666) | 2.86215862 |
| 47 | Increased serum pyruvate (HP:0003542) | 2.86020820 |
| 48 | Abnormality of glycolysis (HP:0004366) | 2.86020820 |
| 49 | Disinhibition (HP:0000734) | 2.84189899 |
| 50 | Lethargy (HP:0001254) | 2.81656142 |
| 51 | Neuroendocrine neoplasm (HP:0100634) | 2.78716583 |
| 52 | Obstructive lung disease (HP:0006536) | 2.77090287 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77090287 |
| 54 | Abnormality of renal resorption (HP:0011038) | 2.76998925 |
| 55 | Nausea (HP:0002018) | 2.71964609 |
| 56 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.70613080 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.70613080 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.70535460 |
| 59 | Ketosis (HP:0001946) | 2.69661292 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.69246017 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68833790 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68833790 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68833790 |
| 64 | Myocardial infarction (HP:0001658) | 2.66837711 |
| 65 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.66092248 |
| 66 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65640771 |
| 67 | Increased serum lactate (HP:0002151) | 2.64390184 |
| 68 | Petechiae (HP:0000967) | 2.63302859 |
| 69 | Increased serum ferritin (HP:0003281) | 2.63264333 |
| 70 | Leukodystrophy (HP:0002415) | 2.56560526 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.53629482 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53629482 |
| 73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.48138055 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.48085130 |
| 75 | Hyperventilation (HP:0002883) | 2.47194163 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.46749889 |
| 77 | Hypolipoproteinemia (HP:0010981) | 2.39622269 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.38324058 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.38027261 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35719642 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.35719642 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.35055576 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34062924 |
| 84 | CNS demyelination (HP:0007305) | 2.33777393 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.33391841 |
| 86 | Metabolic acidosis (HP:0001942) | 2.31421756 |
| 87 | Amyloidosis (HP:0011034) | 2.31345189 |
| 88 | Joint hemorrhage (HP:0005261) | 2.29824981 |
| 89 | Hyperglycinemia (HP:0002154) | 2.27008793 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 2.25157395 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.25066273 |
| 92 | Multiple enchondromatosis (HP:0005701) | 2.24453107 |
| 93 | Hyperglycinuria (HP:0003108) | 2.22809819 |
| 94 | Prolonged partial thromboplastin time (HP:0003645) | 2.22166469 |
| 95 | Palpitations (HP:0001962) | 2.21876350 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21647234 |
| 97 | Hypothermia (HP:0002045) | 2.21547883 |
| 98 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.21255417 |
| 99 | Ventricular fibrillation (HP:0001663) | 2.20064146 |
| 100 | Neoplasm of head and neck (HP:0012288) | 2.19967171 |
| 101 | Esophageal neoplasm (HP:0100751) | 2.19967171 |
| 102 | Vomiting (HP:0002013) | 2.19782506 |
| 103 | Methylmalonic acidemia (HP:0002912) | 2.17066167 |
| 104 | Abnormal ciliary motility (HP:0012262) | 2.16302479 |
| 105 | Syncope (HP:0001279) | 2.15551462 |
| 106 | Mutism (HP:0002300) | 2.14348715 |
| 107 | Gait imbalance (HP:0002141) | 2.13768985 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.13255299 |
| 109 | Malnutrition (HP:0004395) | 2.13099507 |
| 110 | Nephritis (HP:0000123) | 2.12430825 |
| 111 | Epileptic encephalopathy (HP:0200134) | 2.11600018 |
| 112 | Abnormal pupillary function (HP:0007686) | 2.10790496 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.09644371 |
| 114 | Congenital primary aphakia (HP:0007707) | 2.09581028 |
| 115 | Abnormal urine phosphate concentration (HP:0012599) | 2.08953646 |
| 116 | Myokymia (HP:0002411) | 2.08699417 |
| 117 | Intrahepatic cholestasis (HP:0001406) | 2.08250004 |
| 118 | Agnosia (HP:0010524) | 2.07550199 |
| 119 | Progressive neurologic deterioration (HP:0002344) | 2.07247485 |
| 120 | Autoimmune thrombocytopenia (HP:0001973) | 2.07040698 |
| 121 | X-linked dominant inheritance (HP:0001423) | 2.05839562 |
| 122 | Hyperammonemia (HP:0001987) | 2.05548536 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05268224 |
| 124 | Ragged-red muscle fibers (HP:0003200) | 2.03159120 |
| 125 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.02467005 |
| 126 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01271920 |
| 127 | Abnormality of glycine metabolism (HP:0010895) | 2.01063119 |
| 128 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.01063119 |
| 129 | Prolonged QT interval (HP:0001657) | 2.00894326 |
| 130 | Hypoglycemic seizures (HP:0002173) | 2.00861627 |
| 131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99534213 |
| 132 | Sudden death (HP:0001699) | 1.98715279 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.97348024 |
| 134 | Emotional lability (HP:0000712) | 1.94864171 |
| 135 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92693824 |
| 136 | Hypoalphalipoproteinemia (HP:0003233) | 1.91503807 |
| 137 | Symptomatic seizures (HP:0011145) | 1.91175049 |
| 138 | Pathologic fracture (HP:0002756) | 1.91157600 |
| 139 | Exertional dyspnea (HP:0002875) | 1.90367530 |
| 140 | Renal cortical cysts (HP:0000803) | 1.89349324 |
| 141 | Poor head control (HP:0002421) | 1.89320490 |
| 142 | Atonic seizures (HP:0010819) | 1.88556064 |
| 143 | Gout (HP:0001997) | 1.88381305 |
| 144 | Absence seizures (HP:0002121) | 1.88251445 |
| 145 | Reduced antithrombin III activity (HP:0001976) | 1.87078491 |
| 146 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.84226874 |
| 147 | Dialeptic seizures (HP:0011146) | 1.83732064 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.83669091 |
| 149 | Recurrent skin infections (HP:0001581) | 1.83545637 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.83420845 |
| 151 | Abnormality of proline metabolism (HP:0010907) | 1.83420845 |
| 152 | Myoglobinuria (HP:0002913) | 1.82524623 |
| 153 | Renal tubular dysfunction (HP:0000124) | 1.82237735 |
| 154 | Retinal atrophy (HP:0001105) | 1.81398074 |
| 155 | Exercise-induced myalgia (HP:0003738) | 1.81321046 |
| 156 | Generalized tonic-clonic seizures (HP:0002069) | 1.80941483 |
| 157 | Abnormal trabecular bone morphology (HP:0100671) | 1.80825311 |
| 158 | Abnormal gallbladder physiology (HP:0012438) | 1.80662340 |
| 159 | Cholecystitis (HP:0001082) | 1.80662340 |
| 160 | Personality changes (HP:0000751) | 1.80368935 |
| 161 | Meningitis (HP:0001287) | 1.79519824 |
| 162 | Rough bone trabeculation (HP:0100670) | 1.79215840 |
| 163 | Febrile seizures (HP:0002373) | 1.78803926 |
| 164 | Decreased circulating renin level (HP:0003351) | 1.75409090 |
| 165 | Conjunctival telangiectasia (HP:0000524) | 1.74302294 |
| 166 | Metaphyseal irregularity (HP:0003025) | 1.74226753 |
| 167 | Peripheral demyelination (HP:0011096) | 1.73638939 |
| 168 | Hyperlipoproteinemia (HP:0010980) | 1.72706611 |
| 169 | Increased IgM level (HP:0003496) | 1.72099669 |
| 170 | Nuclear cataract (HP:0100018) | 1.72060857 |
| 171 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71897457 |
| 172 | Myositis (HP:0100614) | 1.71688113 |
| 173 | Left ventricular hypertrophy (HP:0001712) | 1.71428535 |
| 174 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.71086339 |
| 175 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.70805613 |
| 176 | Xanthomatosis (HP:0000991) | 1.70250248 |
| 177 | Hypertensive crisis (HP:0100735) | 1.69258687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.93182772 |
| 2 | CASK | 3.83775805 |
| 3 | BCKDK | 3.16178849 |
| 4 | PIM2 | 3.10560779 |
| 5 | NME1 | 2.96954718 |
| 6 | LMTK2 | 2.95146230 |
| 7 | INSRR | 2.79443800 |
| 8 | ERN1 | 2.75325264 |
| 9 | NTRK3 | 2.72416234 |
| 10 | TESK2 | 2.54936652 |
| 11 | VRK2 | 2.50692112 |
| 12 | EPHA4 | 2.47312509 |
| 13 | MAP3K12 | 2.36171178 |
| 14 | MAP3K11 | 2.35785795 |
| 15 | WNK4 | 2.20350138 |
| 16 | MAP2K7 | 2.18316561 |
| 17 | MYLK | 2.15391811 |
| 18 | MAPK15 | 2.14521359 |
| 19 | TAOK2 | 2.12405837 |
| 20 | GRK7 | 2.05099260 |
| 21 | TYK2 | 2.03016799 |
| 22 | MAP4K1 | 2.01406111 |
| 23 | MAP2K3 | 1.83723828 |
| 24 | KDR | 1.78747695 |
| 25 | ACVR1B | 1.76463496 |
| 26 | TGFBR2 | 1.74322236 |
| 27 | TBK1 | 1.73373969 |
| 28 | MAP3K4 | 1.71050453 |
| 29 | PHKG1 | 1.67099785 |
| 30 | PHKG2 | 1.67099785 |
| 31 | OXSR1 | 1.66041228 |
| 32 | MAP3K3 | 1.63224054 |
| 33 | GRK5 | 1.61248057 |
| 34 | BLK | 1.59704066 |
| 35 | OBSCN | 1.57870215 |
| 36 | MAP3K14 | 1.52588223 |
| 37 | STK16 | 1.44036211 |
| 38 | MATK | 1.42461646 |
| 39 | STK39 | 1.41505468 |
| 40 | FRK | 1.40525341 |
| 41 | MAP2K4 | 1.40193242 |
| 42 | PINK1 | 1.37931663 |
| 43 | NEK1 | 1.37375681 |
| 44 | AKT3 | 1.37357567 |
| 45 | BUB1 | 1.37284851 |
| 46 | BMPR2 | 1.36068141 |
| 47 | WNK3 | 1.35953047 |
| 48 | MUSK | 1.34646788 |
| 49 | IRAK3 | 1.33857966 |
| 50 | DAPK2 | 1.30190222 |
| 51 | JAK3 | 1.29743501 |
| 52 | IKBKB | 1.28435519 |
| 53 | CAMK2D | 1.27232700 |
| 54 | TNIK | 1.27189289 |
| 55 | CAMK2B | 1.27147326 |
| 56 | CAMK2A | 1.25508267 |
| 57 | PAK4 | 1.22179506 |
| 58 | ADRBK2 | 1.21645423 |
| 59 | ARAF | 1.20138708 |
| 60 | MST4 | 1.16093574 |
| 61 | PRKCG | 1.15811210 |
| 62 | TESK1 | 1.15610675 |
| 63 | PNCK | 1.12836537 |
| 64 | BCR | 1.12586630 |
| 65 | MAP3K1 | 1.12489896 |
| 66 | PRKCE | 1.12007985 |
| 67 | STK38L | 1.11254045 |
| 68 | CAMK2G | 1.10837913 |
| 69 | FGR | 1.08609681 |
| 70 | SMG1 | 1.07397860 |
| 71 | EIF2AK1 | 1.06430901 |
| 72 | DDR2 | 1.05312925 |
| 73 | CSF1R | 1.04982830 |
| 74 | CSK | 1.04781575 |
| 75 | MINK1 | 0.96372430 |
| 76 | IRAK4 | 0.95839168 |
| 77 | PDK2 | 0.95396030 |
| 78 | PLK2 | 0.94620529 |
| 79 | BMPR1B | 0.91096793 |
| 80 | PRPF4B | 0.91048003 |
| 81 | MST1R | 0.90263193 |
| 82 | ADRBK1 | 0.89713785 |
| 83 | ZAP70 | 0.89163131 |
| 84 | MAPK13 | 0.89131962 |
| 85 | GRK1 | 0.88448817 |
| 86 | PDK4 | 0.87114193 |
| 87 | PDK3 | 0.87114193 |
| 88 | PAK3 | 0.86781229 |
| 89 | EIF2AK3 | 0.86760835 |
| 90 | LYN | 0.85778433 |
| 91 | PRKACA | 0.84565492 |
| 92 | IRAK2 | 0.84333155 |
| 93 | IKBKE | 0.83538264 |
| 94 | SYK | 0.83182039 |
| 95 | TAOK1 | 0.82876531 |
| 96 | KIT | 0.82546936 |
| 97 | PIK3CG | 0.81601491 |
| 98 | MAP3K8 | 0.81383990 |
| 99 | STK10 | 0.80609320 |
| 100 | PIK3CA | 0.80346511 |
| 101 | NTRK1 | 0.79605928 |
| 102 | FES | 0.78136343 |
| 103 | ERBB4 | 0.77628557 |
| 104 | SGK494 | 0.76690253 |
| 105 | SGK223 | 0.76690253 |
| 106 | TLK1 | 0.76419501 |
| 107 | BTK | 0.75498107 |
| 108 | PBK | 0.72623745 |
| 109 | PAK1 | 0.72028160 |
| 110 | BRAF | 0.71404683 |
| 111 | MOS | 0.71108150 |
| 112 | VRK1 | 0.70779954 |
| 113 | DAPK3 | 0.70298689 |
| 114 | PIM1 | 0.70258849 |
| 115 | TXK | 0.69867455 |
| 116 | SCYL2 | 0.69244447 |
| 117 | PRKG2 | 0.65884790 |
| 118 | MARK1 | 0.63501809 |
| 119 | MAP3K2 | 0.63284903 |
| 120 | DAPK1 | 0.62957333 |
| 121 | PKN1 | 0.62297656 |
| 122 | MAPK12 | 0.62233604 |
| 123 | CDK19 | 0.61987475 |
| 124 | CAMKK2 | 0.61745462 |
| 125 | CDK5 | 0.61369861 |
| 126 | NTRK2 | 0.60476980 |
| 127 | IRAK1 | 0.60376867 |
| 128 | ZAK | 0.59839442 |
| 129 | PRKCA | 0.59576551 |
| 130 | LRRK2 | 0.58801088 |
| 131 | ILK | 0.57999471 |
| 132 | RIPK4 | 0.57705318 |
| 133 | ABL2 | 0.56965138 |
| 134 | LIMK1 | 0.56557616 |
| 135 | NEK6 | 0.54755124 |
| 136 | UHMK1 | 0.54575346 |
| 137 | PRKACG | 0.54399151 |
| 138 | SIK3 | 0.53431757 |
| 139 | LCK | 0.53355798 |
| 140 | MAP3K5 | 0.52790956 |
| 141 | TIE1 | 0.52584530 |
| 142 | DYRK1A | 0.52166441 |
| 143 | PRKG1 | 0.51971211 |
| 144 | ITK | 0.50868979 |
| 145 | CDK4 | 0.50375468 |
| 146 | CDC7 | 0.49020160 |
| 147 | MAP2K1 | 0.47851365 |
| 148 | MAPK11 | 0.46431054 |
| 149 | TEC | 0.44427518 |
| 150 | MAPK7 | 0.44256959 |
| 151 | MAP2K6 | 0.43339576 |
| 152 | CDC42BPA | 0.43128703 |
| 153 | CSNK2A1 | 0.43079218 |
| 154 | CDK8 | 0.41416672 |
| 155 | HCK | 0.40467604 |
| 156 | NEK9 | 0.40182516 |
| 157 | CSNK1G3 | 0.39749953 |
| 158 | PDPK1 | 0.39667022 |
| 159 | PRKCQ | 0.38520995 |
| 160 | MARK3 | 0.38037965 |
| 161 | CDK6 | 0.36781694 |
| 162 | CLK1 | 0.36256564 |
| 163 | PRKAA2 | 0.35553105 |
| 164 | MAP2K2 | 0.35377721 |
| 165 | PRKCZ | 0.34604238 |
| 166 | CSNK1A1 | 0.34307862 |
| 167 | SGK2 | 0.34180016 |
| 168 | PRKCD | 0.33576024 |
| 169 | RPS6KC1 | 0.33195230 |
| 170 | RPS6KL1 | 0.33195230 |
| 171 | SRPK1 | 0.31144019 |
| 172 | CCNB1 | 0.30406410 |
| 173 | STK4 | 0.30168674 |
| 174 | RPS6KA5 | 0.29132427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.71809965 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.76079752 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 2.99788135 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75883371 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.75071548 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.53457796 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.43700282 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.42227246 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.22096220 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.18407104 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.15404782 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04879609 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.96537174 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.93644080 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92558274 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.89798434 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.89756179 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88989222 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84009685 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83175892 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81813275 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.80098708 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.76783377 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75676396 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69771426 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67170125 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62861255 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.61415779 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61133331 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.59214776 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57604449 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57593628 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51233637 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50479566 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49040657 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.48614334 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.48073564 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39861361 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39693129 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37310719 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30764551 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29983735 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28311762 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.26512194 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.19949039 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19679568 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19484522 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19077874 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16909221 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16597338 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15974195 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14703588 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.14457380 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14328202 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 1.13720387 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09714581 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 1.08340732 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07036308 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 1.06330747 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04831837 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 1.01243306 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00408234 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00272953 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99154625 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.96755646 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94261123 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93092416 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92417970 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90600479 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89880861 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89171445 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88894441 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87439566 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.86793170 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.86304559 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86295964 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86052271 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85655116 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84960892 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83871274 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81922298 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81156518 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80798825 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80217972 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80168323 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79338522 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78973571 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.78731562 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77182697 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76897988 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76345194 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.75915688 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75467204 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74756838 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74185187 |
| 96 | Base excision repair_Homo sapiens_hsa03410 | 0.73861006 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73671305 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72829021 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.70651819 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68229664 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68072859 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67255663 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.61950374 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61307054 |
| 105 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59838349 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.58407064 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58043129 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57133700 |
| 109 | Phototransduction_Homo sapiens_hsa04744 | 0.55652457 |
| 110 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55599233 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55555696 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54598782 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54424649 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53879116 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.53546136 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53434820 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53023163 |
| 118 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52868495 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52789671 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52386940 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52175973 |
| 122 | Mismatch repair_Homo sapiens_hsa03430 | 0.52162842 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.51696597 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50105019 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49486778 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48843669 |
| 127 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48345455 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48257737 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48125737 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44887285 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44242608 |
| 132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43967808 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43108564 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42583354 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.41459345 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40266796 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39846421 |
| 138 | Proteasome_Homo sapiens_hsa03050 | 0.38993129 |
| 139 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38272198 |
| 140 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37960003 |
| 141 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35427031 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35155245 |
| 143 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35101612 |
| 144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34784738 |

